We are live on ! Find out more
VTVT icon

vTv Therapeutics

44 hedge funds and large institutions have $22.1M invested in vTv Therapeutics in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

109% more capital inflows, than outflows

Capital inflows: $2.73M | Capital outflows: $1.31M

19% more funds holding

Funds holding: 37 → 44 (+7)

2.63% more ownership

Funds ownership: 35.29% → 37.92% (+2.6%)

8% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 12

Holders
44
Holders Change
+7
Holders Change %
+18.92%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
12
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

VTVT Hedge Fund Activity: Q4 2017 in Review

44 of the 4,421 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q4 2017, worth a combined $22.1M — up 8.1% from $20.4M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new VTVT positions and 2 closed out — a net gain of 7 holders — while 13 added to existing stakes and 12 trimmed.

The largest buyer was Royce & Associates, opening a new position worth an estimated $1.26M. The largest seller was BlackRock, cutting an estimated $391K.

  • 44 institutional investors held vTv Therapeutics (VTVT) as of Q4 2017, up from 37 in Q3 2017.
  • Funds reported $22.1M of vTv Therapeutics stock for Q4 2017, up 8.1% quarter-over-quarter.
  • 9 funds opened new vTv Therapeutics positions in Q4 2017 and 2 closed out, a net change of +7 holders.
  • The largest vTv Therapeutics buyer in Q4 2017 was Royce & Associates, an estimated $1.26M added.
  • The largest vTv Therapeutics seller in Q4 2017 was BlackRock, an estimated $391K sold.

Based on aggregated 13F filings for Q4 2017.